Gastric and Small Bowel Tumors.

Area of Science:

• Oncology
• Gastroenterology
• Surgical Oncology

Background:

• Gastric adenocarcinoma incidence has declined in the US over 70 years but retains a poor prognosis.
• Radical resection was the historical primary treatment for stomach cancer.
• Systemic chemotherapy and radiation therapy are now integral to prolonging survival.

Purpose of the Study:

• To review current evidence guiding gastric cancer treatment.
• To discuss management of gastrointestinal stromal tumors (GIST) and small bowel tumors.
• To explore surgical strategies, including lymph node dissection extent.

Main Methods:

• Literature review of evidence-based treatments for gastric cancer.
• Discussion of systemic therapies (chemotherapy, radiation).
• Analysis of surgical management for gastric and small bowel tumors.

Main Results:

• Current treatment paradigms integrate systemic therapies with surgical resection.
• The extent of gastric lymph node dissection is a critical surgical consideration.
• Evidence guides multimodal treatment approaches for various gastrointestinal malignancies.

Conclusions:

• Multimodal treatment strategies are essential for managing gastric cancer.
• Surgical management, including lymph node dissection, remains crucial.
• Comprehensive understanding of systemic and surgical options improves patient outcomes.